Humanigen, Inc.
USD0.00
-0.00 (-84.62%)
CEO
Cameron Durrant MBA
IPO Date
2013-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.24
Volume
2.06M
| -0.9 |
| 31 Dec 2020 | FY | 100.0% | -29125.3% | -199.5% | -133.0% | 0.00 | 3.34 | -7.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 81.3% | -2226.2% | -0.45 | 0.03 | -4.7 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 148.0% | -876.2% | -0.43 | 0.16 | -5.5 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 90.3% | -1316.6% | -0.80 | 0.06 | -0.3 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 617.0% | -572.7% | -0.98 | 0.58 | -2.2 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -617.2% | -317.4% | 0.00 | 0.00 | -2.8 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | -154.4% | -88.4% | 0.44 | 2.34 | -1.5 |
| 31 Dec 2013 | FY | 100.0% | -95336.4% | -69.3% | -53.3% | 0.16 | 6.83 | -2.6 |
| 0.4 |
| 30 Sept 2022 | Q3 | 100.0% | -10573.3% | 44.6% | -90.0% | 0.00 | 0.34 | -0.1 |
| 30 Jun 2022 | Q2 | 100.0% | -2913.0% | 60.3% | -61.0% | -0.51 | 0.64 | -1.0 |
| 31 Mar 2022 | Q1 | 100.0% | -2055.3% | 85.0% | -29.9% | -1.01 | 1.00 | -2.3 |
| 31 Dec 2021 | Q4 | 100.0% | -3234.3% | 141.6% | -47.2% | -1.06 | 1.03 | -1.8 |
| 30 Sept 2021 | Q3 | 100.0% | -6442.0% | 378.3% | -85.6% | -1.41 | 1.13 | -1.3 |
| 30 Jun 2021 | Q2 | 100.0% | -6834.3% | -162.0% | -58.2% | 0.56 | 2.42 | -3.6 |
| 31 Mar 2021 | Q1 | 100.0% | -13491.2% | -385.2% | -66.3% | 1.44 | 1.85 | -3.8 |
| 31 Dec 2020 | Q4 | 100.0% | -10351.0% | -70.9% | -47.3% | 0.00 | 3.34 | -7.0 |